Stay updated with breaking news from Cue Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Goldman Sachs Group cut shares of Cue Health (NASDAQ:HLTH – Get Rating) from a buy rating to a neutral rating in a research note released on Friday, The Fly reports. Separately, BTIG Research decreased their price objective on Cue Health from $5.00 to $3.00 in a report on Monday, May 15th. Cue Health Trading […]
Cue Health (NASDAQ:HLTH – Get Rating) was downgraded by analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research report issued on Friday, The Fly reports. Separately, BTIG Research decreased their target price on shares of Cue Health from $5.00 to $3.00 in a research note on Monday, […]
Cue Health (NASDAQ:HLTH – Get Rating) and Talis Biomedical (NASDAQ:TLIS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Cue Health and […]
Cue Health Inc. (NASDAQ:HLTH – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 2,770,000 shares, a decrease of 7.0% from the March 31st total of 2,980,000 shares. Based on an average daily trading volume, of 261,400 shares, […]
10x Genomics (NASDAQ:TXG – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, valuation and earnings. Analyst Ratings This is a breakdown of recent recommendations and […]